nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Thiotepa—hematologic cancer	0.0493	0.0959	CbGbCtD
Tramadol—CYP2B6—Ifosfamide—hematologic cancer	0.028	0.0544	CbGbCtD
Tramadol—CYP2D6—Lomustine—hematologic cancer	0.0267	0.052	CbGbCtD
Tramadol—CYP2B6—Nilotinib—hematologic cancer	0.0243	0.0472	CbGbCtD
Tramadol—CYP2D6—Idarubicin—hematologic cancer	0.0238	0.0463	CbGbCtD
Tramadol—CYP2D6—Hydroxyurea—hematologic cancer	0.0202	0.0394	CbGbCtD
Tramadol—CYP3A4—Bexarotene—hematologic cancer	0.0183	0.0356	CbGbCtD
Tramadol—CYP2D6—Bortezomib—hematologic cancer	0.0176	0.0343	CbGbCtD
Tramadol—CYP3A4—Busulfan—hematologic cancer	0.017	0.0331	CbGbCtD
Tramadol—CYP3A4—Lomustine—hematologic cancer	0.017	0.0331	CbGbCtD
Tramadol—CYP2B6—Irinotecan—hematologic cancer	0.0167	0.0325	CbGbCtD
Tramadol—CYP3A4—Thiotepa—hematologic cancer	0.0151	0.0295	CbGbCtD
Tramadol—CYP2B6—Cisplatin—hematologic cancer	0.0136	0.0265	CbGbCtD
Tramadol—CYP2D6—Imatinib—hematologic cancer	0.0129	0.0251	CbGbCtD
Tramadol—CYP3A4—Methoxsalen—hematologic cancer	0.0118	0.0229	CbGbCtD
Tramadol—CYP2D6—Nilotinib—hematologic cancer	0.0117	0.0228	CbGbCtD
Tramadol—CYP2D6—Vinorelbine—hematologic cancer	0.0116	0.0226	CbGbCtD
Tramadol—CYP3A4—Bortezomib—hematologic cancer	0.0112	0.0218	CbGbCtD
Tramadol—CYP2B6—Dexamethasone—hematologic cancer	0.011	0.0214	CbGbCtD
Tramadol—CYP3A4—Daunorubicin—hematologic cancer	0.0107	0.0208	CbGbCtD
Tramadol—CYP3A4—Cytarabine—hematologic cancer	0.00945	0.0184	CbGbCtD
Tramadol—CYP3A4—Teniposide—hematologic cancer	0.00931	0.0181	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—hematologic cancer	0.00912	0.0177	CbGbCtD
Tramadol—CYP3A4—Ifosfamide—hematologic cancer	0.00859	0.0167	CbGbCtD
Tramadol—CYP3A4—Imatinib—hematologic cancer	0.00821	0.016	CbGbCtD
Tramadol—CYP3A4—Ruxolitinib—hematologic cancer	0.00773	0.015	CbGbCtD
Tramadol—CYP3A4—Nilotinib—hematologic cancer	0.00746	0.0145	CbGbCtD
Tramadol—CYP3A4—Vinorelbine—hematologic cancer	0.0074	0.0144	CbGbCtD
Tramadol—CYP2D6—Vinblastine—hematologic cancer	0.00717	0.0139	CbGbCtD
Tramadol—CYP3A4—Triamcinolone—hematologic cancer	0.00676	0.0132	CbGbCtD
Tramadol—CYP3A4—Dasatinib—hematologic cancer	0.00659	0.0128	CbGbCtD
Tramadol—CYP3A4—Mitoxantrone—hematologic cancer	0.00651	0.0127	CbGbCtD
Tramadol—CYP3A4—Betamethasone—hematologic cancer	0.0058	0.0113	CbGbCtD
Tramadol—CYP3A4—Prednisolone—hematologic cancer	0.00573	0.0111	CbGbCtD
Tramadol—CYP3A4—Prednisone—hematologic cancer	0.00541	0.0105	CbGbCtD
Tramadol—CYP2D6—Dexamethasone—hematologic cancer	0.00531	0.0103	CbGbCtD
Tramadol—CYP3A4—Irinotecan—hematologic cancer	0.00513	0.00997	CbGbCtD
Tramadol—CYP3A4—Vinblastine—hematologic cancer	0.00456	0.00887	CbGbCtD
Tramadol—CYP3A4—Vincristine—hematologic cancer	0.00448	0.00872	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—hematologic cancer	0.0044	0.00857	CbGbCtD
Tramadol—CYP3A4—Etoposide—hematologic cancer	0.00411	0.00799	CbGbCtD
Tramadol—CYP3A4—Dexamethasone—hematologic cancer	0.00338	0.00657	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—hematologic cancer	0.0028	0.00545	CbGbCtD
Tramadol—Venlafaxine—ABCG2—hematologic cancer	0.00117	0.626	CrCbGaD
Tramadol—Venlafaxine—ABCB1—hematologic cancer	0.000486	0.26	CrCbGaD
Tramadol—GRIN3A—testis—hematologic cancer	0.000216	0.106	CbGeAlD
Tramadol—Dextromethorphan—ABCB1—hematologic cancer	0.000213	0.114	CrCbGaD
Tramadol—OPRM1—hematopoietic system—hematologic cancer	0.000189	0.0928	CbGeAlD
Tramadol—SLC6A4—hematopoietic system—hematologic cancer	0.000157	0.0772	CbGeAlD
Tramadol—OPRM1—blood—hematologic cancer	0.000125	0.0615	CbGeAlD
Tramadol—SLC6A2—gonad—hematologic cancer	0.000105	0.0517	CbGeAlD
Tramadol—SLC6A4—blood—hematologic cancer	0.000104	0.0511	CbGeAlD
Tramadol—OPRM1—testis—hematologic cancer	0.000104	0.0509	CbGeAlD
Tramadol—CYP2B6—hematopoietic system—hematologic cancer	0.000102	0.0501	CbGeAlD
Tramadol—SLC6A4—lung—hematologic cancer	9.13e-05	0.0448	CbGeAlD
Tramadol—SLC6A2—lung—hematologic cancer	8.04e-05	0.0395	CbGeAlD
Tramadol—CYP2B6—gonad—hematologic cancer	7.75e-05	0.0381	CbGeAlD
Tramadol—CYP3A4—hematopoietic system—hematologic cancer	7.7e-05	0.0378	CbGeAlD
Tramadol—CHRM3—testis—hematologic cancer	7.68e-05	0.0377	CbGeAlD
Tramadol—SLC6A2—testis—hematologic cancer	7.58e-05	0.0372	CbGeAlD
Tramadol—CYP2D6—hematopoietic system—hematologic cancer	7.58e-05	0.0372	CbGeAlD
Tramadol—CYP2B6—blood—hematologic cancer	6.76e-05	0.0332	CbGeAlD
Tramadol—CYP2B6—lung—hematologic cancer	5.92e-05	0.0291	CbGeAlD
Tramadol—CYP2B6—testis—hematologic cancer	5.59e-05	0.0274	CbGeAlD
Tramadol—SLC6A2—lymph node—hematologic cancer	5.5e-05	0.027	CbGeAlD
Tramadol—CYP3A4—blood—hematologic cancer	5.1e-05	0.025	CbGeAlD
Tramadol—CYP2D6—blood—hematologic cancer	5.02e-05	0.0247	CbGeAlD
Tramadol—CYP2D6—testis—hematologic cancer	4.15e-05	0.0204	CbGeAlD
Tramadol—Tinnitus—Doxorubicin—hematologic cancer	1.51e-05	3.76e-05	CcSEcCtD
Tramadol—Anaemia—Methotrexate—hematologic cancer	1.51e-05	3.75e-05	CcSEcCtD
Tramadol—Feeling abnormal—Dexamethasone—hematologic cancer	1.5e-05	3.75e-05	CcSEcCtD
Tramadol—Feeling abnormal—Betamethasone—hematologic cancer	1.5e-05	3.75e-05	CcSEcCtD
Tramadol—Flushing—Doxorubicin—hematologic cancer	1.5e-05	3.75e-05	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—hematologic cancer	1.5e-05	3.75e-05	CcSEcCtD
Tramadol—Flatulence—Epirubicin—hematologic cancer	1.5e-05	3.74e-05	CcSEcCtD
Tramadol—Tension—Epirubicin—hematologic cancer	1.5e-05	3.73e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Betamethasone—hematologic cancer	1.49e-05	3.72e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.49e-05	3.72e-05	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—hematologic cancer	1.49e-05	3.72e-05	CcSEcCtD
Tramadol—Hypersensitivity—Triamcinolone—hematologic cancer	1.48e-05	3.7e-05	CcSEcCtD
Tramadol—Nervousness—Epirubicin—hematologic cancer	1.48e-05	3.69e-05	CcSEcCtD
Tramadol—Back pain—Epirubicin—hematologic cancer	1.47e-05	3.67e-05	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—hematologic cancer	1.47e-05	3.66e-05	CcSEcCtD
Tramadol—Malaise—Methotrexate—hematologic cancer	1.47e-05	3.66e-05	CcSEcCtD
Tramadol—Dizziness—Etoposide—hematologic cancer	1.47e-05	3.66e-05	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—hematologic cancer	1.47e-05	3.65e-05	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—hematologic cancer	1.46e-05	3.65e-05	CcSEcCtD
Tramadol—Vertigo—Methotrexate—hematologic cancer	1.46e-05	3.65e-05	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—hematologic cancer	1.46e-05	3.64e-05	CcSEcCtD
Tramadol—Chills—Doxorubicin—hematologic cancer	1.45e-05	3.62e-05	CcSEcCtD
Tramadol—Urticaria—Betamethasone—hematologic cancer	1.45e-05	3.62e-05	CcSEcCtD
Tramadol—Urticaria—Dexamethasone—hematologic cancer	1.45e-05	3.62e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.45e-05	3.61e-05	CcSEcCtD
Tramadol—Dizziness—Prednisolone—hematologic cancer	1.45e-05	3.61e-05	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—hematologic cancer	1.45e-05	3.61e-05	CcSEcCtD
Tramadol—Asthenia—Triamcinolone—hematologic cancer	1.44e-05	3.6e-05	CcSEcCtD
Tramadol—Body temperature increased—Betamethasone—hematologic cancer	1.44e-05	3.6e-05	CcSEcCtD
Tramadol—Body temperature increased—Dexamethasone—hematologic cancer	1.44e-05	3.6e-05	CcSEcCtD
Tramadol—Abdominal pain—Betamethasone—hematologic cancer	1.44e-05	3.6e-05	CcSEcCtD
Tramadol—Abdominal pain—Dexamethasone—hematologic cancer	1.44e-05	3.6e-05	CcSEcCtD
Tramadol—Nausea—Cisplatin—hematologic cancer	1.44e-05	3.59e-05	CcSEcCtD
Tramadol—Insomnia—Prednisone—hematologic cancer	1.44e-05	3.58e-05	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—hematologic cancer	1.44e-05	3.58e-05	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—hematologic cancer	1.43e-05	3.56e-05	CcSEcCtD
Tramadol—Pruritus—Triamcinolone—hematologic cancer	1.42e-05	3.55e-05	CcSEcCtD
Tramadol—Cough—Methotrexate—hematologic cancer	1.42e-05	3.54e-05	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—hematologic cancer	1.42e-05	3.54e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—hematologic cancer	1.41e-05	3.52e-05	CcSEcCtD
Tramadol—Convulsion—Methotrexate—hematologic cancer	1.41e-05	3.52e-05	CcSEcCtD
Tramadol—Vomiting—Etoposide—hematologic cancer	1.41e-05	3.52e-05	CcSEcCtD
Tramadol—Erythema—Doxorubicin—hematologic cancer	1.41e-05	3.51e-05	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—hematologic cancer	1.41e-05	3.51e-05	CcSEcCtD
Tramadol—Anaemia—Epirubicin—hematologic cancer	1.41e-05	3.51e-05	CcSEcCtD
Tramadol—Agitation—Epirubicin—hematologic cancer	1.4e-05	3.49e-05	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—hematologic cancer	1.4e-05	3.49e-05	CcSEcCtD
Tramadol—Rash—Etoposide—hematologic cancer	1.4e-05	3.49e-05	CcSEcCtD
Tramadol—Dermatitis—Etoposide—hematologic cancer	1.4e-05	3.48e-05	CcSEcCtD
Tramadol—Headache—Etoposide—hematologic cancer	1.39e-05	3.46e-05	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—hematologic cancer	1.39e-05	3.46e-05	CcSEcCtD
Tramadol—Chest pain—Methotrexate—hematologic cancer	1.39e-05	3.45e-05	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—hematologic cancer	1.39e-05	3.45e-05	CcSEcCtD
Tramadol—Myalgia—Methotrexate—hematologic cancer	1.39e-05	3.45e-05	CcSEcCtD
Tramadol—Tension—Doxorubicin—hematologic cancer	1.38e-05	3.45e-05	CcSEcCtD
Tramadol—Decreased appetite—Prednisone—hematologic cancer	1.38e-05	3.45e-05	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—hematologic cancer	1.38e-05	3.44e-05	CcSEcCtD
Tramadol—Rash—Prednisolone—hematologic cancer	1.38e-05	3.44e-05	CcSEcCtD
Tramadol—Dermatitis—Prednisolone—hematologic cancer	1.38e-05	3.44e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.38e-05	3.43e-05	CcSEcCtD
Tramadol—Malaise—Epirubicin—hematologic cancer	1.37e-05	3.42e-05	CcSEcCtD
Tramadol—Fatigue—Prednisone—hematologic cancer	1.37e-05	3.42e-05	CcSEcCtD
Tramadol—Headache—Prednisolone—hematologic cancer	1.37e-05	3.42e-05	CcSEcCtD
Tramadol—Discomfort—Methotrexate—hematologic cancer	1.37e-05	3.41e-05	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—hematologic cancer	1.37e-05	3.41e-05	CcSEcCtD
Tramadol—Vertigo—Epirubicin—hematologic cancer	1.37e-05	3.41e-05	CcSEcCtD
Tramadol—Syncope—Epirubicin—hematologic cancer	1.37e-05	3.41e-05	CcSEcCtD
Tramadol—Back pain—Doxorubicin—hematologic cancer	1.36e-05	3.4e-05	CcSEcCtD
Tramadol—Constipation—Prednisone—hematologic cancer	1.36e-05	3.39e-05	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—hematologic cancer	1.36e-05	3.38e-05	CcSEcCtD
Tramadol—Palpitations—Epirubicin—hematologic cancer	1.35e-05	3.36e-05	CcSEcCtD
Tramadol—Confusional state—Methotrexate—hematologic cancer	1.34e-05	3.34e-05	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—hematologic cancer	1.34e-05	3.34e-05	CcSEcCtD
Tramadol—Dizziness—Triamcinolone—hematologic cancer	1.33e-05	3.32e-05	CcSEcCtD
Tramadol—Cough—Epirubicin—hematologic cancer	1.33e-05	3.31e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—hematologic cancer	1.33e-05	3.31e-05	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—hematologic cancer	1.33e-05	3.31e-05	CcSEcCtD
Tramadol—Convulsion—Epirubicin—hematologic cancer	1.32e-05	3.29e-05	CcSEcCtD
Tramadol—Infection—Methotrexate—hematologic cancer	1.32e-05	3.29e-05	CcSEcCtD
Tramadol—Nausea—Etoposide—hematologic cancer	1.32e-05	3.28e-05	CcSEcCtD
Tramadol—Hypertension—Epirubicin—hematologic cancer	1.32e-05	3.28e-05	CcSEcCtD
Tramadol—Feeling abnormal—Prednisone—hematologic cancer	1.31e-05	3.27e-05	CcSEcCtD
Tramadol—Asthenia—Betamethasone—hematologic cancer	1.31e-05	3.27e-05	CcSEcCtD
Tramadol—Asthenia—Dexamethasone—hematologic cancer	1.31e-05	3.27e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—hematologic cancer	1.31e-05	3.26e-05	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—hematologic cancer	1.3e-05	3.25e-05	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—hematologic cancer	1.3e-05	3.25e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—hematologic cancer	1.3e-05	3.24e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Prednisone—hematologic cancer	1.3e-05	3.24e-05	CcSEcCtD
Tramadol—Nausea—Prednisolone—hematologic cancer	1.3e-05	3.24e-05	CcSEcCtD
Tramadol—Chest pain—Epirubicin—hematologic cancer	1.3e-05	3.23e-05	CcSEcCtD
Tramadol—Myalgia—Epirubicin—hematologic cancer	1.3e-05	3.23e-05	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—hematologic cancer	1.3e-05	3.23e-05	CcSEcCtD
Tramadol—Agitation—Doxorubicin—hematologic cancer	1.3e-05	3.23e-05	CcSEcCtD
Tramadol—Anxiety—Epirubicin—hematologic cancer	1.29e-05	3.22e-05	CcSEcCtD
Tramadol—Pruritus—Betamethasone—hematologic cancer	1.29e-05	3.22e-05	CcSEcCtD
Tramadol—Pruritus—Dexamethasone—hematologic cancer	1.29e-05	3.22e-05	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—hematologic cancer	1.29e-05	3.22e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.29e-05	3.21e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—hematologic cancer	1.28e-05	3.2e-05	CcSEcCtD
Tramadol—Discomfort—Epirubicin—hematologic cancer	1.28e-05	3.19e-05	CcSEcCtD
Tramadol—Vomiting—Triamcinolone—hematologic cancer	1.28e-05	3.19e-05	CcSEcCtD
Tramadol—Malaise—Doxorubicin—hematologic cancer	1.27e-05	3.17e-05	CcSEcCtD
Tramadol—Rash—Triamcinolone—hematologic cancer	1.27e-05	3.16e-05	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—hematologic cancer	1.27e-05	3.16e-05	CcSEcCtD
Tramadol—Dermatitis—Triamcinolone—hematologic cancer	1.27e-05	3.16e-05	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—hematologic cancer	1.27e-05	3.16e-05	CcSEcCtD
Tramadol—Anorexia—Methotrexate—hematologic cancer	1.27e-05	3.16e-05	CcSEcCtD
Tramadol—Syncope—Doxorubicin—hematologic cancer	1.26e-05	3.15e-05	CcSEcCtD
Tramadol—Urticaria—Prednisone—hematologic cancer	1.26e-05	3.15e-05	CcSEcCtD
Tramadol—Headache—Triamcinolone—hematologic cancer	1.26e-05	3.14e-05	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—hematologic cancer	1.26e-05	3.13e-05	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—hematologic cancer	1.26e-05	3.13e-05	CcSEcCtD
Tramadol—Confusional state—Epirubicin—hematologic cancer	1.25e-05	3.13e-05	CcSEcCtD
Tramadol—Diarrhoea—Betamethasone—hematologic cancer	1.25e-05	3.11e-05	CcSEcCtD
Tramadol—Diarrhoea—Dexamethasone—hematologic cancer	1.25e-05	3.11e-05	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—hematologic cancer	1.25e-05	3.11e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—hematologic cancer	1.24e-05	3.1e-05	CcSEcCtD
Tramadol—Hypotension—Methotrexate—hematologic cancer	1.24e-05	3.09e-05	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—hematologic cancer	1.24e-05	3.09e-05	CcSEcCtD
Tramadol—Infection—Epirubicin—hematologic cancer	1.24e-05	3.08e-05	CcSEcCtD
Tramadol—Cough—Doxorubicin—hematologic cancer	1.23e-05	3.07e-05	CcSEcCtD
Tramadol—Shock—Epirubicin—hematologic cancer	1.22e-05	3.05e-05	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—hematologic cancer	1.22e-05	3.04e-05	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—hematologic cancer	1.22e-05	3.04e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—hematologic cancer	1.22e-05	3.03e-05	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—hematologic cancer	1.22e-05	3.03e-05	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—hematologic cancer	1.21e-05	3.03e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.21e-05	3.02e-05	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—hematologic cancer	1.21e-05	3.01e-05	CcSEcCtD
Tramadol—Dizziness—Dexamethasone—hematologic cancer	1.21e-05	3.01e-05	CcSEcCtD
Tramadol—Dizziness—Betamethasone—hematologic cancer	1.21e-05	3.01e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—hematologic cancer	1.2e-05	3e-05	CcSEcCtD
Tramadol—Insomnia—Methotrexate—hematologic cancer	1.2e-05	3e-05	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—hematologic cancer	1.2e-05	2.99e-05	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—hematologic cancer	1.2e-05	2.99e-05	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—hematologic cancer	1.2e-05	2.99e-05	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—hematologic cancer	1.2e-05	2.98e-05	CcSEcCtD
Tramadol—Nausea—Triamcinolone—hematologic cancer	1.2e-05	2.98e-05	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—hematologic cancer	1.19e-05	2.97e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.19e-05	2.97e-05	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—hematologic cancer	1.19e-05	2.96e-05	CcSEcCtD
Tramadol—Anorexia—Epirubicin—hematologic cancer	1.19e-05	2.95e-05	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—hematologic cancer	1.18e-05	2.95e-05	CcSEcCtD
Tramadol—Somnolence—Methotrexate—hematologic cancer	1.18e-05	2.94e-05	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—hematologic cancer	1.17e-05	2.93e-05	CcSEcCtD
Tramadol—Hypersensitivity—Prednisone—hematologic cancer	1.17e-05	2.92e-05	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—hematologic cancer	1.17e-05	2.92e-05	CcSEcCtD
Tramadol—Hypotension—Epirubicin—hematologic cancer	1.16e-05	2.9e-05	CcSEcCtD
Tramadol—Vomiting—Dexamethasone—hematologic cancer	1.16e-05	2.89e-05	CcSEcCtD
Tramadol—Vomiting—Betamethasone—hematologic cancer	1.16e-05	2.89e-05	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—hematologic cancer	1.16e-05	2.89e-05	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—hematologic cancer	1.16e-05	2.88e-05	CcSEcCtD
Tramadol—Rash—Dexamethasone—hematologic cancer	1.15e-05	2.87e-05	CcSEcCtD
Tramadol—Rash—Betamethasone—hematologic cancer	1.15e-05	2.87e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—hematologic cancer	1.15e-05	2.87e-05	CcSEcCtD
Tramadol—Dermatitis—Dexamethasone—hematologic cancer	1.15e-05	2.87e-05	CcSEcCtD
Tramadol—Dermatitis—Betamethasone—hematologic cancer	1.15e-05	2.87e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.15e-05	2.86e-05	CcSEcCtD
Tramadol—Fatigue—Methotrexate—hematologic cancer	1.15e-05	2.86e-05	CcSEcCtD
Tramadol—Headache—Dexamethasone—hematologic cancer	1.14e-05	2.85e-05	CcSEcCtD
Tramadol—Headache—Betamethasone—hematologic cancer	1.14e-05	2.85e-05	CcSEcCtD
Tramadol—Infection—Doxorubicin—hematologic cancer	1.14e-05	2.85e-05	CcSEcCtD
Tramadol—Asthenia—Prednisone—hematologic cancer	1.14e-05	2.84e-05	CcSEcCtD
Tramadol—Pain—Methotrexate—hematologic cancer	1.14e-05	2.83e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.13e-05	2.82e-05	CcSEcCtD
Tramadol—Shock—Doxorubicin—hematologic cancer	1.13e-05	2.82e-05	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—hematologic cancer	1.13e-05	2.81e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—hematologic cancer	1.13e-05	2.81e-05	CcSEcCtD
Tramadol—Pruritus—Prednisone—hematologic cancer	1.13e-05	2.8e-05	CcSEcCtD
Tramadol—Insomnia—Epirubicin—hematologic cancer	1.12e-05	2.8e-05	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—hematologic cancer	1.12e-05	2.8e-05	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—hematologic cancer	1.12e-05	2.79e-05	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—hematologic cancer	1.12e-05	2.78e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—hematologic cancer	1.11e-05	2.77e-05	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—hematologic cancer	1.11e-05	2.76e-05	CcSEcCtD
Tramadol—Somnolence—Epirubicin—hematologic cancer	1.11e-05	2.76e-05	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—hematologic cancer	1.1e-05	2.73e-05	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—hematologic cancer	1.1e-05	2.73e-05	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—hematologic cancer	1.09e-05	2.73e-05	CcSEcCtD
Tramadol—Diarrhoea—Prednisone—hematologic cancer	1.09e-05	2.71e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—hematologic cancer	1.09e-05	2.71e-05	CcSEcCtD
Tramadol—Nausea—Betamethasone—hematologic cancer	1.08e-05	2.7e-05	CcSEcCtD
Tramadol—Nausea—Dexamethasone—hematologic cancer	1.08e-05	2.7e-05	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—hematologic cancer	1.08e-05	2.69e-05	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—hematologic cancer	1.08e-05	2.68e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.07e-05	2.68e-05	CcSEcCtD
Tramadol—Fatigue—Epirubicin—hematologic cancer	1.07e-05	2.67e-05	CcSEcCtD
Tramadol—Constipation—Epirubicin—hematologic cancer	1.06e-05	2.65e-05	CcSEcCtD
Tramadol—Pain—Epirubicin—hematologic cancer	1.06e-05	2.65e-05	CcSEcCtD
Tramadol—Urticaria—Methotrexate—hematologic cancer	1.06e-05	2.63e-05	CcSEcCtD
Tramadol—Dizziness—Prednisone—hematologic cancer	1.05e-05	2.62e-05	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—hematologic cancer	1.05e-05	2.62e-05	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—hematologic cancer	1.05e-05	2.62e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.05e-05	2.61e-05	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—hematologic cancer	1.04e-05	2.59e-05	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—hematologic cancer	1.03e-05	2.58e-05	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—hematologic cancer	1.03e-05	2.56e-05	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—hematologic cancer	1.02e-05	2.55e-05	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—hematologic cancer	1.02e-05	2.55e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—hematologic cancer	1.02e-05	2.53e-05	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—hematologic cancer	1.01e-05	2.52e-05	CcSEcCtD
Tramadol—Vomiting—Prednisone—hematologic cancer	1.01e-05	2.52e-05	CcSEcCtD
Tramadol—Rash—Prednisone—hematologic cancer	1e-05	2.5e-05	CcSEcCtD
Tramadol—Dermatitis—Prednisone—hematologic cancer	1e-05	2.5e-05	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—hematologic cancer	1e-05	2.49e-05	CcSEcCtD
Tramadol—Headache—Prednisone—hematologic cancer	9.96e-06	2.48e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.93e-06	2.48e-05	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—hematologic cancer	9.92e-06	2.47e-05	CcSEcCtD
Tramadol—Urticaria—Epirubicin—hematologic cancer	9.88e-06	2.46e-05	CcSEcCtD
Tramadol—Constipation—Doxorubicin—hematologic cancer	9.84e-06	2.45e-05	CcSEcCtD
Tramadol—Pain—Doxorubicin—hematologic cancer	9.84e-06	2.45e-05	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—hematologic cancer	9.83e-06	2.45e-05	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—hematologic cancer	9.83e-06	2.45e-05	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—hematologic cancer	9.79e-06	2.44e-05	CcSEcCtD
Tramadol—Asthenia—Methotrexate—hematologic cancer	9.54e-06	2.38e-05	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—hematologic cancer	9.48e-06	2.36e-05	CcSEcCtD
Tramadol—Nausea—Prednisone—hematologic cancer	9.45e-06	2.35e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.41e-06	2.35e-05	CcSEcCtD
Tramadol—Pruritus—Methotrexate—hematologic cancer	9.4e-06	2.34e-05	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—hematologic cancer	9.16e-06	2.28e-05	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—hematologic cancer	9.14e-06	2.28e-05	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—hematologic cancer	9.1e-06	2.27e-05	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—hematologic cancer	9.1e-06	2.27e-05	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—hematologic cancer	9.09e-06	2.27e-05	CcSEcCtD
Tramadol—Asthenia—Epirubicin—hematologic cancer	8.92e-06	2.22e-05	CcSEcCtD
Tramadol—Pruritus—Epirubicin—hematologic cancer	8.8e-06	2.19e-05	CcSEcCtD
Tramadol—Dizziness—Methotrexate—hematologic cancer	8.79e-06	2.19e-05	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—hematologic cancer	8.51e-06	2.12e-05	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—hematologic cancer	8.48e-06	2.11e-05	CcSEcCtD
Tramadol—Vomiting—Methotrexate—hematologic cancer	8.45e-06	2.11e-05	CcSEcCtD
Tramadol—Rash—Methotrexate—hematologic cancer	8.38e-06	2.09e-05	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—hematologic cancer	8.37e-06	2.09e-05	CcSEcCtD
Tramadol—Headache—Methotrexate—hematologic cancer	8.33e-06	2.07e-05	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—hematologic cancer	8.26e-06	2.06e-05	CcSEcCtD
Tramadol—Dizziness—Epirubicin—hematologic cancer	8.22e-06	2.05e-05	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—hematologic cancer	8.14e-06	2.03e-05	CcSEcCtD
Tramadol—Vomiting—Epirubicin—hematologic cancer	7.91e-06	1.97e-05	CcSEcCtD
Tramadol—Nausea—Methotrexate—hematologic cancer	7.89e-06	1.97e-05	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—hematologic cancer	7.87e-06	1.96e-05	CcSEcCtD
Tramadol—Rash—Epirubicin—hematologic cancer	7.84e-06	1.95e-05	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—hematologic cancer	7.83e-06	1.95e-05	CcSEcCtD
Tramadol—Headache—Epirubicin—hematologic cancer	7.79e-06	1.94e-05	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—hematologic cancer	7.61e-06	1.9e-05	CcSEcCtD
Tramadol—Nausea—Epirubicin—hematologic cancer	7.39e-06	1.84e-05	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—hematologic cancer	7.32e-06	1.82e-05	CcSEcCtD
Tramadol—Rash—Doxorubicin—hematologic cancer	7.26e-06	1.81e-05	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—hematologic cancer	7.25e-06	1.81e-05	CcSEcCtD
Tramadol—Headache—Doxorubicin—hematologic cancer	7.21e-06	1.8e-05	CcSEcCtD
Tramadol—Nausea—Doxorubicin—hematologic cancer	6.84e-06	1.7e-05	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—NOTCH1—hematologic cancer	5.4e-06	6.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—hematologic cancer	5.4e-06	6.68e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	5.38e-06	6.65e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.37e-06	6.65e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	5.36e-06	6.63e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.36e-06	6.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	5.33e-06	6.59e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.3e-06	6.56e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.3e-06	6.56e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	5.3e-06	6.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD80—hematologic cancer	5.29e-06	6.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—hematologic cancer	5.28e-06	6.53e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIT—hematologic cancer	5.28e-06	6.53e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—hematologic cancer	5.28e-06	6.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	5.27e-06	6.52e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EP300—hematologic cancer	5.24e-06	6.48e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	5.24e-06	6.47e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTPN11—hematologic cancer	5.19e-06	6.42e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGF2—hematologic cancer	5.18e-06	6.4e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	5.18e-06	6.4e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.17e-06	6.39e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC2—hematologic cancer	5.15e-06	6.37e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—hematologic cancer	5.13e-06	6.34e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—hematologic cancer	5.12e-06	6.33e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	5.11e-06	6.32e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—hematologic cancer	5.1e-06	6.3e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—hematologic cancer	5.1e-06	6.3e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK3—hematologic cancer	5.06e-06	6.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CREBBP—hematologic cancer	5.04e-06	6.24e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREB1—hematologic cancer	5.03e-06	6.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NUP98—hematologic cancer	5.01e-06	6.19e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—hematologic cancer	4.99e-06	6.18e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—hematologic cancer	4.98e-06	6.16e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—hematologic cancer	4.97e-06	6.14e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	4.97e-06	6.14e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JAK2—hematologic cancer	4.96e-06	6.14e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL2—hematologic cancer	4.92e-06	6.08e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—hematologic cancer	4.92e-06	6.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6R—hematologic cancer	4.91e-06	6.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	4.91e-06	6.07e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—hematologic cancer	4.9e-06	6.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREBBP—hematologic cancer	4.9e-06	6.06e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.87e-06	6.02e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.86e-06	6.01e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.86e-06	6.01e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—hematologic cancer	4.85e-06	5.99e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	4.83e-06	5.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NUP214—hematologic cancer	4.83e-06	5.97e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—hematologic cancer	4.82e-06	5.96e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—hematologic cancer	4.81e-06	5.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—hematologic cancer	4.78e-06	5.91e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.77e-06	5.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FN1—hematologic cancer	4.75e-06	5.88e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.73e-06	5.85e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTR—hematologic cancer	4.73e-06	5.85e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—hematologic cancer	4.72e-06	5.84e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	4.72e-06	5.83e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MTOR—hematologic cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BAD—hematologic cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—hematologic cancer	4.68e-06	5.79e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAP2K1—hematologic cancer	4.68e-06	5.78e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	4.65e-06	5.75e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—hematologic cancer	4.64e-06	5.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—hematologic cancer	4.64e-06	5.73e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—hematologic cancer	4.6e-06	5.69e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—hematologic cancer	4.6e-06	5.68e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—hematologic cancer	4.57e-06	5.65e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	4.56e-06	5.64e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD80—hematologic cancer	4.56e-06	5.64e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIT—hematologic cancer	4.55e-06	5.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	4.55e-06	5.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	4.55e-06	5.62e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—hematologic cancer	4.55e-06	5.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3R1—hematologic cancer	4.52e-06	5.58e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.51e-06	5.58e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	4.5e-06	5.57e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.5e-06	5.56e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—hematologic cancer	4.47e-06	5.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	4.47e-06	5.53e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF2—hematologic cancer	4.45e-06	5.5e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	4.42e-06	5.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SDC1—hematologic cancer	4.39e-06	5.43e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3R1—hematologic cancer	4.39e-06	5.42e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.38e-06	5.42e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.38e-06	5.42e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	4.38e-06	5.41e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	4.36e-06	5.39e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	4.35e-06	5.38e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CREBBP—hematologic cancer	4.34e-06	5.37e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—hematologic cancer	4.34e-06	5.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREB1—hematologic cancer	4.33e-06	5.35e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—hematologic cancer	4.33e-06	5.35e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—hematologic cancer	4.31e-06	5.33e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—hematologic cancer	4.31e-06	5.33e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—hematologic cancer	4.3e-06	5.32e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—hematologic cancer	4.28e-06	5.29e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JAK2—hematologic cancer	4.26e-06	5.27e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL2—hematologic cancer	4.24e-06	5.24e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6R—hematologic cancer	4.22e-06	5.22e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—hematologic cancer	4.22e-06	5.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—hematologic cancer	4.22e-06	5.22e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	4.22e-06	5.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—hematologic cancer	4.21e-06	5.21e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—hematologic cancer	4.18e-06	5.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—hematologic cancer	4.17e-06	5.15e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—hematologic cancer	4.16e-06	5.15e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	4.12e-06	5.09e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—hematologic cancer	4.11e-06	5.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	4.08e-06	5.05e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—hematologic cancer	4.07e-06	5.04e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—hematologic cancer	4.06e-06	5.02e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTOR—hematologic cancer	4.05e-06	5.01e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—hematologic cancer	4.05e-06	5.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	4.03e-06	4.98e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—hematologic cancer	4.01e-06	4.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	4e-06	4.94e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	4e-06	4.94e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	3.99e-06	4.93e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	3.97e-06	4.91e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	3.96e-06	4.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	3.92e-06	4.84e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—hematologic cancer	3.89e-06	4.8e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.89e-06	4.8e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.88e-06	4.8e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.87e-06	4.79e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	3.87e-06	4.78e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF2—hematologic cancer	3.83e-06	4.73e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	3.8e-06	4.7e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—hematologic cancer	3.78e-06	4.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	3.78e-06	4.67e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	3.76e-06	4.65e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—hematologic cancer	3.75e-06	4.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NQO1—hematologic cancer	3.74e-06	4.62e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD44—hematologic cancer	3.74e-06	4.62e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—hematologic cancer	3.72e-06	4.6e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—hematologic cancer	3.72e-06	4.6e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—hematologic cancer	3.7e-06	4.58e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—hematologic cancer	3.7e-06	4.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	3.68e-06	4.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JAK2—hematologic cancer	3.67e-06	4.54e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—hematologic cancer	3.64e-06	4.51e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—hematologic cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—hematologic cancer	3.62e-06	4.48e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—hematologic cancer	3.62e-06	4.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—hematologic cancer	3.6e-06	4.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	3.6e-06	4.45e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—hematologic cancer	3.59e-06	4.44e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.59e-06	4.43e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—hematologic cancer	3.58e-06	4.43e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYCS—hematologic cancer	3.54e-06	4.37e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.51e-06	4.34e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	3.51e-06	4.34e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—hematologic cancer	3.5e-06	4.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTOR—hematologic cancer	3.49e-06	4.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	3.49e-06	4.31e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	3.48e-06	4.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—hematologic cancer	3.44e-06	4.25e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—hematologic cancer	3.43e-06	4.25e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	3.42e-06	4.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	3.41e-06	4.22e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	3.4e-06	4.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—hematologic cancer	3.39e-06	4.19e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	3.38e-06	4.18e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—hematologic cancer	3.34e-06	4.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	3.33e-06	4.12e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—hematologic cancer	3.29e-06	4.07e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	3.27e-06	4.04e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.25e-06	4.02e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—hematologic cancer	3.24e-06	4.01e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	3.24e-06	4e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—hematologic cancer	3.21e-06	3.96e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—hematologic cancer	3.2e-06	3.96e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—hematologic cancer	3.19e-06	3.94e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—hematologic cancer	3.17e-06	3.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	3.16e-06	3.91e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—hematologic cancer	3.15e-06	3.89e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—hematologic cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—hematologic cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—hematologic cancer	3.12e-06	3.86e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—hematologic cancer	3.12e-06	3.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.12e-06	3.85e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—hematologic cancer	3.11e-06	3.85e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—hematologic cancer	3.1e-06	3.83e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	3.02e-06	3.73e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.02e-06	3.73e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—hematologic cancer	3.01e-06	3.72e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—hematologic cancer	3.01e-06	3.72e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.99e-06	3.7e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—hematologic cancer	2.96e-06	3.65e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.95e-06	3.65e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	2.95e-06	3.64e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	2.94e-06	3.63e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.91e-06	3.59e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.9e-06	3.59e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.87e-06	3.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—hematologic cancer	2.87e-06	3.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.86e-06	3.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.86e-06	3.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.86e-06	3.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—hematologic cancer	2.82e-06	3.49e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—hematologic cancer	2.79e-06	3.45e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—hematologic cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	2.72e-06	3.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—hematologic cancer	2.69e-06	3.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—hematologic cancer	2.69e-06	3.32e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—hematologic cancer	2.69e-06	3.32e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—hematologic cancer	2.66e-06	3.29e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.57e-06	3.18e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—hematologic cancer	2.54e-06	3.15e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.54e-06	3.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.53e-06	3.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—hematologic cancer	2.5e-06	3.1e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	2.5e-06	3.09e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	2.47e-06	3.05e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.39e-06	2.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—hematologic cancer	2.35e-06	2.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—hematologic cancer	2.31e-06	2.86e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.28e-06	2.82e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—hematologic cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.13e-06	2.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	2.12e-06	2.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—hematologic cancer	2.08e-06	2.57e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—hematologic cancer	2.06e-06	2.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—hematologic cancer	2.05e-06	2.54e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—hematologic cancer	2.02e-06	2.49e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.97e-06	2.44e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.97e-06	2.43e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—hematologic cancer	1.88e-06	2.33e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—hematologic cancer	1.85e-06	2.28e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—hematologic cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.77e-06	2.18e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—hematologic cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—hematologic cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.93e-07	1.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—hematologic cancer	8.12e-07	1e-05	CbGpPWpGaD
